MTOR and myeloid sarcoma: The pathways of programmed cell death, FoxOs, mTOR, AMPK, and SIRT1 offer great promise for the understanding and treatment of cognitive loss in MS, but future investigations will be necessary to further understand the complexity of these pathways to achieve long-lasting beneficial outcomes.